Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability.
Small Methods. 2023 Jun;7(6):e2201605. doi: 10.1002/smtd.202201605. Epub 2023 Mar 12.
Small Methods. 2023.
PMID: 36908010
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanisms.
Dinter L, Karitzky PC, Schulz A, Wurm AA, Mehnert MC, Sergon M, Tunger A, Lesche M, Wehner R, Müller A, Käubler T, Niessner H, Dahl A, Beissert S, Schmitz M, Meier F, Seliger B, Westphal D.
Dinter L, et al. Among authors: mehnert mc.
Int J Cancer. 2024 Mar 15;154(6):1057-1072. doi: 10.1002/ijc.34807. Epub 2023 Dec 11.
Int J Cancer. 2024.
PMID: 38078628
Item in Clipboard
FLT3-directed UniCAR T-cell therapy of acute myeloid leukaemia.
Peschke JC, Bergmann R, Mehnert M, Gonzalez Soto KE, Loureiro LR, Mitwasi N, Kegler A, Altmann H, Wobus M, Máthé D, Szigeti K, Feldmann A, Bornhäuser M, Bachmann M, Fasslrinner F, Arndt C.
Peschke JC, et al.
Br J Haematol. 2023 Sep;202(6):1137-1150. doi: 10.1111/bjh.18971. Epub 2023 Jul 17.
Br J Haematol. 2023.
PMID: 37460273
Item in Clipboard
Cite
Cite